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Metformin, an antidiabetic agent, patentiates insulin action and reduces insulin resistance. We examined the antihypertensive effects and vascular effects of metformin in spontaneously hypertensive rats (SHR). Wistar-Kyoto normotensivc (WKY) and SHR were injected with metformin (100 mglkg) or saline subcutaneously twice daily for 4 weeks. Blood pressure was recorded by a tail-cuff plethesmographic method. Metformin treatment significantly attenuated (P < -05) the increase in blood pressure in metfortnin treated SHR versus untreated control SHR. At the end of the experimental period of 4 weeks, metformin-treated SHR had a mean blood pressure that was 34 mm lower than th&t of untreated SHR. Metformin treatment had no significant effect on blood pressure in WKY rats. Treatment of SHR aortic smooth muscle (SM) cells with metformin (2 pgIrnl.1 for 24 h signibcantly decreased (P < .05) arginine vasopressin-and thrombin-stimulated increase in [ Ca2' 1;. However, metformin treatment did not have a signiiicant effect on the basal [Ca2'li.
Incubation of SHR aortic SM cells with OH-t-arginine
I25 to 100 pmol/L) for 24 h increased nitrite production in a dose dependent manner. Metformin (5 pg/mL) treatment of SM cells increased nitrite production at all concentrations of OH-L-arginine; however, differences were significant (P < ,051 only at 25 and 50 pmol/L OH-L-arginine. These results suggest that metformin may be decreasing arterial pressure in the SHR, at least in part, by attenuating the agonist-stimuiated i Ca" 3 i response in SHR vascular smooth muscle cells. Am J Hypertens 1996; 9:570-576 KEY WORDS: Metformin, spontaneously hypertensive rat, blood pressure, cytosolic calcium, image analysis, vascular smooth muscle cells, nitric oxide, Wistar-Kyoto rat. E piderniological and clinical evidence supprt the concept that there is a strong association between insukin insensitivity, obesity, and hypertension and that there is a direct corre-versity of lowa Colhe d !hkine, Iowa City, IA 52242. lation between the degree of insulin resistance and the severity of hypertension.'~'" Mormver, metformin, an antidiabetic agent that potentiates insulin action and reduces insulin resistance,'-' also decreases blood pressure in spontaneously h yrtensive rats ',* as well as in hypertensive patients. ," However, the underlying mechanistns of the antihypertensive effects of metformin are not fully understood. Some preliminary observations suggest that metformin may be mediating its antihypertensive effects through direct effects on the bid vessel wall. It has been shown that metformin attenuates potassium induced contraction of rat caudal artery rings." Similarly, insulin In this study, we have examined tf.e txffects ot dailv injections of metformin for 4 weeks OD blood pressu~ c' in spontaneousIy hypertensive rats (SHZ) and WistarKyoto (WKY) rats. U'e have also test& whether metformin has direct effects on VSM cc% b:; ::~r~~.ring the effect of mptfnr;r,ln Pn agonist-stimulated [ Ca '+ 1, and OH-:.-arginine dependent nitrite production in SHR VSM cells. Our results demonstrate that metfurmin attenuated the increase in blood pressure in SHR while it had no effect in WKY rats. Our results also indicate that metformin directly interacts with VS_&l cells to decrease agonist-stimulated [Ca" I1 and increase nitrite production ITI the SHR VSM cells incubated with OH-L-arginine. It is possible that metformin may be producing antihypertensive effects in SHR, at least in par!, by attenslating agonist-stimulated [Ca"], with a concomitant decrease in peripheral vascular resistance.
MATERIALS AND METHODS

Animals and Cultured Artc la1 Smooth Muscle Cells
Age matched ma!e SHR and WKY rats (6 to 8 weeks old 1 were obtain4 from Harlan !Indianap&s, IN) at least 1 week prior t J the experiment, and were fti a standard pellet diet and luster ad libitum. SHR and WKY rats were injected with metformin (100 mg/ kg) or saline subcutaneously twice a day for 4 weeks. Systolic pressure of control and metiormin treated WK'I: and SHR was determined in the unanesthetized state by the tail plethesmographic method using an automated cuff inflator pulse reading system that utilizes a photoelectric senmr (IITC, Lending, NJ) .2' Prior to recording the blood pressure, rats were accustomed to confinement by putting them in appropriate sized rat 3slders for 3 consecutive day; for ,Xl min each under a heat lamp. After this conditioning @ad, the rats were put into holders for 20 to 30 min before blood pressure were measured for both control and metformin treated rats under identical conditions. Systolic pressure was read from the chart readout as the level at which pulsations reappeared during the gradual deflation of the cuff and an average of three to five recordings were taken per rat on a given day. It has been demonstrated that systolic blood pressure mearurd by a photoelectric senmr i; in vev close agreement with blood pressure readings taken concurrently from femck ral cathetersnz Smmth muscle cells from the thoracic aorta were culturd essentially as described pre~-iously.'z7 Cells were subcultured every week. In the studies described in this article, we used cells between thr second and ninth passages. The purity of VSM c&s wti confirmed by immun*tiemical locarization of smooth muscle specific actin u:sing monoclonal ant&diE r?iL<L +;itiW the KH:-terrninal de apeptidc oi L\ 9m&i musik u-dbl. L&ng thm prmedurrs, it was ascertained that all the culti cells had actin stte~ fibers throughout the qtosol suggesting that the procedures used to iwhte and rulturc cells yielded VSM cell frost from contamination with endothelial r.ells and fibrobbsts.Xa Calcium Imaging in Individual VSM Cells Cytocolic free calcium concenhation ( (Ca'-1,) was measured using Fura 2 and a video microscopic digital image analysis system (Photon Technology International, South Brunswick, NJ) to anairz..e ehe calcium responsiveness of individual cells. A Semiconfluent I'SM cells grown on 25mm coverslips were loaded with calcium qxif~ dye Fura 2 ty incubating with Fura 2-acetoxymethyl ester (10 Fmol i t) in Dul~co's modified Eagle's medium (DMEM) containing 0.1% bovine serum albumin (BSA) and 0.02% pluronic F-127 for 45 to 50 min at 37°C. After washing once with DMEM-WA, cells were reincubated in DMEM-BSA for 30 min at 37°C to allow complete hvdrolvsis of Fura 2-acetoxymethyl ester to Fura 2 inside tie cell. Fura 2 loaded cells displayed stable and hrieht fluoresence at 340-. m, and 38Grun excitation, whereas unloaded cells had no detectable autofluorescence. Photo bleaching of Fura 2 loaded cells was kept to a minimum by using 10~7 intensity excitation light and a computer controlled NO. 6 shutter that allowed exposure of cells to light only when images were collected. Intracellular calcium conccntracion was measurd at 3i"C in N-Z-hydroxyethylpiperazinc-hi '-2-trthane sulfonic acid ( HLPES ibuffered (25 mmol / L pH 7.4) Eagle's salt solution containing 0.1% BSA and 10 mmol / 1, sxiium bicarbonate.
Agonists were added as twice concentrated solutions to yield the desired final concentration. To toast the effect of metformi13., cells were prctreatrd with indicated concentrations of metformin 24 h before the calcium measurements. ~letformin ~t'as also present during all subsequent steps of Fura 2 loading and [Cal' 1, measurement. [Ca'* Ii changes in response to agonists were computed f-ram recorded images using a defined mask and the average ICn"li computed in the XI x 50 pixel ar*:a in the center of the cell.
Nitrite As-y For x,-__ 'Irite yoduction aswys, SHK VSM o!lls were grow'n to confluence in 12-well culture C.ishes. Treatments were carried out for 24 h in phenol red fre and arginir,.: free media (Gibco, Grand Island, NY; FK, phenol red fre MEM s&cc amine kit) supplemented with mctformin (5 pg /mL) and /or OH-L-a@ nine (25 to 100 lmol/ L). Nitrite w;1s measured spcctrophotometricaily using Griess reagent,* and expressed as pmol/ I, NO,/mg protein. briefly, 500 PL of culture media was mixed with 50 PL each of 5 mmol /I, sulfanilamide, 2 N HC1, and 6 mmol /L IV-{I-naphthyl)-ethylenediaminc, incubatd at room tcmperaturc for JO min, and the absorkncc of the resulting color product read at 546 nm. After removing the media for the nitrite assay, the celIs bvere washed once each with chilled H?O and 70% ethanol and allnwed tu air dry. Protems wt're scllubilized by adding TXhI PL of 2 k h'd0I-l into each well and incubating the culture dishL3 overnight at room temperature: with constant shaking. Prcltein.; were assayed in microtiter plates using BiuRad (Richmond, CA) protein reagent and reading absc>rbcnce in a microtiter plate reader at 595 nm.
Statistica. \nalysis
Statistical analysis was carried out using Student's I test or one-way analvsis of variance (ANOVA 1. Difrrrences beh.een the treatment groups were considereci significant at I) < .05.
RESULTS
Over the 4 weeks of the study, the hod! weight of metformin treated and metformin untretlted control rats die! not differ either for SHR (control = 339 2 3 & n = 11; treat4 = 333 It 3 g, n = JO) or WKY (control = 532 2 8 g, n = 12; treated = 515 -C 8 g, n = 111 rats. The blood pressure of metformin-treated SHR remained steady between 165 znd 170 mm after the sta.t of treatment with rnetformin, ryh?reas the blood pressure of untreated SHR rose to 200 mm from the starting blood pressure of 175 mm (Figure 1 ) . This pattern of change in blood pressure with increasing tin;t of treatment between control and metformin treated SHR was significantly different I P = .O:!) . Moreover, the pattern of change in blood pressure witii time in cojntrol ~IICI metformin treated SHR wzvs also significantly different (P = .005) as compared to rontrul and metformin treated WKY rats. Metformin treatment apparently decreased (P < .05) the blood pressure in SHR within I week as compared to untreated SHK; however, with repeated measures analysis of \.ariance, the divergence was significa*lt at 2 weeks and thereafter (P < G, with Bonferroni adjnsted alpha j (Figure 1) . At the end of 4 weeks, metiormin-treated SHR had a mean blood pressure that was .M mm lower than that of untreated SHR. Metformin treatment had no s&nificant sustained effect on blood pressure in WKY rats (Figure 1 Ir,cuhation of SHR VSM cells with different concentrations of OI-I-r.-arginine for 24 h increased nitrite production in a concentration dependent manner (Figure 3 ). The addition of mctf3rmin (5 .ug/mL) along with O?I-L-arginine further increased nitrite production at ail concentrations of OH-I.-argininc tested and the differences were significant (EI < .05) at 25 and SO pmol i L OH-t-xginine (Figure 3 ).
DTSCUSSION
The results presented in this article demonstrate that the administration of metformin for 4 we& signiScantly decreased (P < -05) blood pressure in SHK but not in WKY normotensive rats. The cardiovascular +zffects of metforrnin have been amply described in the literature. Steme showed that the injection of 50 and 100 mg/ kg metformin in dogs produced a very rapid hvpotension that reached its maximum within 30 minB The hypotensive action of metformin was not blocked by a tropine. 2nd metformin enhanced the hypotension produced by acetylcholine. These observations suggest a direct effect of metformin on the blood vcsszl wall independent of the endothelium. Further, metformin pretreatment attenuated the hypertensive action of epinephrine and hampered the rise in blood pressure produced bv bilateral corona? artery occlusion.jc' Similar to our findings, metformin administration for 1 week has been shown to lower blood pressure in span t~neuusly hypertensi\.e ra Is but not in WKY nortnotensive rats."" Chan et al have shown that in 12 normotensive NIDDAM patients, metformin treatment for 4 weks resulted in a reduction of body weight, piasma cholesterol corcentration, and erect diastolic blood pressure.'" Similarly, Landin-Wilhelmsen, in a pilot study, has shown that metfotmin treatment of nonobese, nondiatetic, hypertensive p;l:icr.ts improved insulin stTsi!!vit)v, J~Xr,ti& plasma insulin, *&urn cholesterol, and triglycerides, and miIdly decreased blood pressureeY However, these findings in hypertensive patients have vet to be confirmed by other investigators. In addition, metformin was shown to improve cardiac performaxe in streptozotocin diabetic rat. by improving the relaxation rate at increasing. prtload." All these obsen,ations taken tvgether cir.rnl : strate that metformin improves cardiob,, Gular aL_iormaIities associated with NIDDM and ;.;+rtens!on that could be due to its the transport of OH-I,-arginine or increas tht activity of cytc&rome P-450 needs to lx further examined. The increaa NO production has been shown to decrease [Ca"lj via cGMP pathway in VSM cells." It is possible that metformin-mediatd increase in NO produr-tion may rtiult, at least in part, in a decrease in [Ca"],. Alternately, it is possible that metformin may inhibit the receptor effector coupling or downstream r+ ccptor sigzding events resulting in a dmasr in I Ca2' Ii and that the effe& of metformin on agonist-stimulated [ Ca '-]i and NO Frcdu&on from OH-I.-arginine may be coincidental finding> that may or may not be related to each other.
Another class of antidiabetic drugs, thiazolidinediones, h35 !xzE ck:3! 1:' ~ME:* h!mc! pr3cl!Tp in genetically hypertensive rat?. 3ri End to decrease cytmlic calcium in VSM 4l.s. Thus, ciglitazone, which lowers blood pressure in the spontaneously h,vpetiensive rat, also dmeasts I'DCFstimulatttd ancrease in IQ'+ I, in the a7r5 aortk smooth muscle cell line-" More . 
